Pharmacolog has received an order on a DrugLog® system from the Akademiska sjukhuset in Uppsala, Sweden. The system will be used for quality assurance of the installed compounding robot at the newly established Centrala Beredningsenheten.
Akademiska sjukhuset in Uppsala purschase DrugLog® to carry out production qualification of the acquired compounding robot, which means that validations are carried out using a stand-alone equipment. The hospital will take over the extempore drug production of medicines on its own when the agreement with an external party expires in 2019 and has therefore established a new pharmaceutical unit. Drug preparation will be done using a processing robot in a new department called CBE, Central Beredningsenheten. The DrugLog® system will be delivered before the turn of the year and revenue will be taken in 2018.
CEO Mats Högberg comments: “We are very pleased to deliver a DrugLog® to our ‘home hospital’. We have several interesting ongoing collaborations with Akademiska and look forward to collaborating with the newly established processing unit. Akademiska will receive state-of-the-art drug handling where patient safety, good working environment and rational methods of preparation have been a loadstar when designing the new department. DrugLog® has a given place in such an activity and will set a new standard for efficient and patient-safe drug preparations. ”
For more information contact:
Mats Högberg, CEO
Email: mats.hogberg@pharmacolog.com
Phone: +46 70-546 50 21
This information is insider information that Pharmacolog AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, on December 6, 2018 at 11:40.
About Pharmacolog AB
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50.
Download as PDF